Navigation Links
BioStorage Technologies is Set for Expansion and Growth With the Appointment of Gregory Swanberg as Chief Executive Officer
Date:11/8/2010

INDIANAPOLIS, Nov. 8, 2010 /PRNewswire/ -- BioStorage Technologies, a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, today announced that the company has appointed Gregory Swanberg to serve as chief executive officer, effective immediately. Dr. F. John Mills, MD, PhD., will transition from his current role as chief executive officer, but will continue his service as chairman of the board.

Mr. Gregory Swanberg joins BioStorage Technologies with more than 25 years of senior management and executive experience leading operational, sales and corporate support teams. His management experience includes directly overseeing the technical delivery of global outsourced services for critical functions in pharmaceutical manufacturing facilities, public and private research centers, hospitals and clinics and data centers. He has provided management and consulting support domestically and globally for companies like Pfizer, Merck, Genentech, Novartis, Eli Lilly, Morgan Stanley, AT&T, Whirlpool and Lexmark. Swanberg most recently served as the managing director of UMS Advisory, a firm focused on outsourcing and operational excellence primarily in the life science sector. Mr. Swanberg holds a bachelor's degree from the University of Kentucky and master's degrees from Georgia Southern University and Northwestern's Kellogg Graduate School of Management.

In announcing the transition, Dr. Mills commented, "We are extremely pleased to have Greg join BioStorage Technologies and we are confident his experience and skill set in building major outsourcing relationships will offer significant benefit to our company and our customers. Greg's strong track record in leading organizations within healthcare, as well as other high-profile industries will provide new avenues of expansion that I'm confident will bring tremendous value to BioStorage Technologies and our customers."

Dr. Mills has led BioStorage Technologies' strategic direction since co-founding the company in 2003. His leadership and vision has been instrumental in shaping the company's success during years of unprecedented growth both within the company and the sample management industry.  Under his guidance, BioStorage Technologies has become widely recognized as the benchmark in sample management.

The appointment of Mr. Swanberg and the transition of Dr. Mills to chairman of the board are consistent with BioStorage Technologies' long-term management succession plan.

"I am pleased to accept the opportunity to continue to grow BioStorage Technologies in the role of chief executive officer," said Swanberg. "I would like to thank Dr. Mills for his accomplishments over the last seven years at BioStorage Technologies. He has broadened the company's capabilities, service offerings and growth prospects, while establishing the foundation that has led to BioStorage Technologies being widely recognized as the leader in the sample management industry."

BioStorage Technologies stores and manages specimens from the world's largest biopharmaceutical companies and CROs, and as a practitioner of Good Storage Practices, the company is committed to ensuring sample integrity throughout the complete sample life cycle. Utilizing ISISS®, the industry's most advanced sample security and web-based tracking tool, BioStorage also provides a complete FDA-compliant audit trail annotated on every sample.

About BioStorage Technologies, Inc.: BioStorage Technologies, Inc. is the benchmark and global leader in centralized sample management and onsite solutions for the bioscience industry.  Our expertise is in the management of the complete lifecycle of a research sample from the planning, collection, transportation and protection to sample retrieval and storage.  The company offers more than 100,000 square feet of secure, temperature-controlled storage as well as real-time, web-based tracking of research samples, expertise in cold chain logistics and next-day retrieval and shipment of biomaterials.  BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.Press Contact:Michael Clark Miller Brooks, Inc.317-873-8100michael@millerbrooks.com
'/>"/>

SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
2. BioStorage Technologies Appoints New Global Director of Supply Chain
3. BioStorage Technologies to Sponsor and Present Educational Workshops at Annual Biorepositories Conference
4. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
5. The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
6. Medisafe 1 Technologies Presentation on Newly Launched Company Website
7. Shrink Nanotechnologies Unveils Videos of StemDisc450 Prototype Growing Human Embryonic Stem Cells
8. Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference
9. Sandata Technologies Launches Enhanced Location Monitoring
10. Netsmart Technologies Software Supports Shawnee Mental Health Center Integrated Mental Health and Primary Care Initiative
11. BioSpecifics Technologies Corp. Awarded Two Qualifying Therapeutic Discovery Project Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , the ... chains, has published the first annual edition of its Global CSR Risk ... 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly ... ... Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
Breaking Medicine News(10 mins):